ICU MED INC's ticker is ICUI and the CUSIP is 44930G107. A total of 280 filers reported holding ICU MED INC in Q4 2020. The put-call ratio across all filers is 0.03 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,635,755 | -34.4% | 30,550 | -1.8% | 0.00% | -20.0% |
| Q2 2023 | $5,542,600 | +45.0% | 31,105 | +34.3% | 0.01% | +25.0% |
| Q1 2023 | $3,821,958 | +8.9% | 23,169 | +3.9% | 0.00% | 0.0% |
| Q4 2022 | $3,511,016 | +8.7% | 22,295 | +4.0% | 0.00% | 0.0% |
| Q3 2022 | $3,229,000 | -8.0% | 21,443 | +0.4% | 0.00% | 0.0% |
| Q2 2022 | $3,510,000 | -27.9% | 21,356 | -2.3% | 0.00% | 0.0% |
| Q1 2022 | $4,868,000 | -2.6% | 21,863 | +3.8% | 0.00% | +33.3% |
| Q4 2021 | $4,999,000 | -11.1% | 21,061 | -12.6% | 0.00% | 0.0% |
| Q3 2021 | $5,622,000 | +19.1% | 24,090 | +5.1% | 0.00% | 0.0% |
| Q2 2021 | $4,719,000 | -17.1% | 22,928 | -17.2% | 0.00% | 0.0% |
| Q1 2021 | $5,690,000 | -1.7% | 27,697 | +2.7% | 0.00% | 0.0% |
| Q4 2020 | $5,786,000 | +55.4% | 26,972 | +32.4% | 0.00% | +50.0% |
| Q3 2020 | $3,724,000 | -3.2% | 20,375 | -2.4% | 0.00% | -33.3% |
| Q2 2020 | $3,849,000 | +0.2% | 20,878 | +9.7% | 0.00% | 0.0% |
| Q1 2020 | $3,840,000 | +14.4% | 19,030 | +6.1% | 0.00% | +50.0% |
| Q4 2019 | $3,357,000 | -13.8% | 17,941 | -26.5% | 0.00% | -33.3% |
| Q3 2019 | $3,896,000 | +7.0% | 24,415 | +68.9% | 0.00% | 0.0% |
| Q2 2019 | $3,642,000 | -4.9% | 14,459 | -9.7% | 0.00% | 0.0% |
| Q1 2019 | $3,831,000 | +31.5% | 16,012 | +26.3% | 0.00% | 0.0% |
| Q4 2018 | $2,913,000 | -68.4% | 12,681 | -61.1% | 0.00% | -62.5% |
| Q3 2018 | $9,207,000 | -2.3% | 32,559 | +1.4% | 0.01% | -11.1% |
| Q2 2018 | $9,425,000 | +104.1% | 32,095 | +75.4% | 0.01% | +125.0% |
| Q1 2018 | $4,617,000 | +55.3% | 18,294 | +33.0% | 0.00% | +33.3% |
| Q4 2017 | $2,972,000 | -8.4% | 13,757 | -21.2% | 0.00% | 0.0% |
| Q3 2017 | $3,246,000 | +126.8% | 17,468 | +110.5% | 0.00% | +200.0% |
| Q2 2017 | $1,431,000 | -31.0% | 8,297 | -39.0% | 0.00% | -50.0% |
| Q1 2017 | $2,075,000 | -35.9% | 13,597 | -38.1% | 0.00% | -33.3% |
| Q4 2016 | $3,237,000 | +26.2% | 21,964 | +8.2% | 0.00% | +50.0% |
| Q3 2016 | $2,564,000 | +71.2% | 20,291 | +52.7% | 0.00% | 0.0% |
| Q2 2016 | $1,498,000 | +166.5% | 13,290 | +146.3% | 0.00% | +100.0% |
| Q1 2016 | $562,000 | -38.0% | 5,396 | -32.8% | 0.00% | 0.0% |
| Q4 2015 | $906,000 | -49.8% | 8,028 | -51.3% | 0.00% | -50.0% |
| Q3 2015 | $1,805,000 | -19.5% | 16,483 | -29.7% | 0.00% | 0.0% |
| Q2 2015 | $2,243,000 | +37.4% | 23,458 | +33.7% | 0.00% | 0.0% |
| Q1 2015 | $1,633,000 | -64.7% | 17,545 | -68.9% | 0.00% | -50.0% |
| Q4 2014 | $4,627,000 | +180.6% | 56,502 | +119.9% | 0.00% | +300.0% |
| Q3 2014 | $1,649,000 | +5.8% | 25,692 | +0.2% | 0.00% | 0.0% |
| Q2 2014 | $1,558,000 | +101.3% | 25,636 | +98.1% | 0.00% | 0.0% |
| Q1 2014 | $774,000 | -53.7% | 12,939 | -50.7% | 0.00% | -50.0% |
| Q4 2013 | $1,671,000 | +46.8% | 26,223 | +56.5% | 0.00% | +100.0% |
| Q3 2013 | $1,138,000 | +75.6% | 16,754 | +86.3% | 0.00% | 0.0% |
| Q2 2013 | $648,000 | -61.2% | 8,992 | -68.3% | 0.00% | -50.0% |
| Q1 2013 | $1,671,000 | – | 28,335 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EVR Research LP | 22,000 | $4,719,000 | 3.86% |
| NUANCE INVESTMENTS, LLC | 901,483 | $193,359,000 | 3.73% |
| Nitorum Capital, L.P. | 417,241 | $89,494,000 | 3.46% |
| Tamarack Advisers, LP | 73,000 | $15,452,000 | 3.22% |
| PFM Health Sciences, LP | 267,817 | $57,444,000 | 2.02% |
| KIRR MARBACH & CO LLC /IN/ | 22,222 | $4,766,000 | 1.49% |
| PURA VIDA INVESTMENTS, LLC | 174,399 | $37,407,000 | 1.36% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 2,584 | $554,000 | 0.88% |
| Findlay Park Partners LLP | 528,825 | $113,428,000 | 0.79% |
| Altium Capital Management LP | 9,321 | $1,999,000 | 0.75% |